Serum soluble CD163 predicts risk of type 2 diabetes in the general population
Research output: Contribution to journal › Journal article › Research › peer-review
Activation of adipose tissue macrophages with concomitant low-grade inflammation is believed to play a central role in the development of type 2 diabetes. We tested whether a new macrophage-derived biomarker, soluble CD163 (sCD163), identifies at-risk individuals before overt disease has developed.
Original language | English |
---|---|
Journal | Clinical Chemistry |
Volume | 57 |
Issue number | 2 |
Pages (from-to) | 291-7 |
Number of pages | 7 |
ISSN | 0009-9147 |
DOIs | |
Publication status | Published - 1 Feb 2011 |
ID: 34151958